How long should I take cabozantinib?

Cabozantinibis a tyrosine kinase inhibitor used to treat the following patients:< span>1.Advanced renal cell carcinoma(RCC), including with Opdivo (nivolumab)When used in combination as first-line treatment. 2.Hepatocellular carcinoma (HCC) who has been treated with Neshavar(Sorafenib). 3.Local advanced or metastatic differentiated thyroid cancer that progresses after VGEFR targeted therapy and does not respond to radioactive iodine therapy or is not eligible to receive radioactive iodine therapy.

Treatment with cabozantinib is usually continued until the cancer starts to develop. To determine how long patients might take cabozantinib before their cancer started to worsen, researchers measured progression-free survival in clinical trials. The length of time patients take cabozantinib is also affected by the side effects they experience. Treatment needs to be stopped when the patient can no longer tolerate the side effects. Because some patients stopped treatment even when their cancer did not progress, the researchers also measured treatment duration, or how long patients took cabozantinib, to better understand how long patients took cabozantinib.

Meteor-331 patients with renal cell carcinoma treated with cabozantinib 60 mg once daily had a median progression-free survival of 7.4 months and a median treatment duration of 7.6 months. Patients with advanced renal cell carcinoma treated with cabozantinib 60 mg once daily had a median progression-free survival of 8.6 months and a median treatment duration of 6.5 months. 467Patients with advanced liver cancer were treated with carboplatin 60 mg 1 times daily. The median progression-free survival was 5.2 months, and the median treatment duration was 3.8 months. 320pts with previously untreated advanced renal cell carcinoma received cabozantinib 40 mg once daily and Opdivo With 240 mg every 2 weeks 30 minutes, the median progression-free survival was 16.6 months, and the median treatment duration was 20.2 months. AcceptCaboozantinib 60 In patients with advanced differentiated thyroid cancer treated with mg once daily (n=170) or placebo (n=88), the median progression-free survival was 11.0 months. Laos ASEAN Pharmaceuticals, United Pharmaceuticals, Lucius Pharmaceuticals, Element Pharmaceuticals, etc. are produced, and the cost per box is less than 20mg*90 capsules1,000 yuan. The retail price of Everest Pharmaceuticals, Yaopin International and Beacon Pharmaceuticals in Bangladesh is around 20mg*90 capsules 2000 per box. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0